Current status and perspectives of TMIGD2-targeted therapy in thyroid cancer

Authors

  • Kailin Zhao

DOI:

https://doi.org/10.61173/jshcrn49

Keywords:

HHLA 2, TMIGD2, thyroid cancer, therapeutic target

Abstract

In recent studies, TMIGD2 has found that it may play an important role in a new therapeutic target in the process of accurate tumor treatment. High expression of TMIGD2 in HCC and glioma cancer can be used as a potential therapeutic target, and some studies showed that the expression level of TMIGD2 in thyroid cancer tissue is also higher than that in normal thyroid tissue, and its expression level is correlated with the malignancy and poor prognosis of tumors. These more cutting-edge findings suggest that TMIGD2 may be used as a potential target for the treatment of thyroid cancer for precise treatment. This article will introduce the current situation and development trend of TMIGD2 in the clinical precision treatment of thyroid cancer.

References

[1] Boulhen C, et al.TMIGD2 as a potential therapeutic target in glioma patients.Front Immunol.2023;14:1173518. doi: 10.3389/ fimmu.2023.1173518. - DOI - PMC - PubMed

[2] Xie Ruihua, Ji Hongli, Fu Wanfa. Expression of HHLA 2 and TMIGD2 and their clinicopathological significance in colorectal cancer tissues [J]. Journal of Gastroenterology and Hepatology, 2021,30 (04): 391-395.

[3] Fu Yuanyuan, Zheng Panpan, Kong Caixia, etc. Expression of HHLA 2 and its receptor TMIGD2 in ovarian cancer tissues and its clinical significance [J]. Chinese Journal of Biological Oncology, 2022,29 (09): 822-827.

[4] Chai Jing, Zhang Jiahong, Li Mengxue. Expression of TMIGD2, TIGIT and its correlation with clinicopathological features in endometrial cancer tissues [J]. Journal of Modern Laboratory Medicine, 2023,38 (06): 87-91 + 158.

[5] Sun Qi, Li Jingjing, Liu Bin. HHLA 2 / TMIGD2 in solid tumors [J]. Chinese Journal of Biological Therapy of Oncology, 2019,26 (12): 1405-1409.

[6] Z h a n g L , F e n g Q , Wa n g J , Ta n Z , L i Q , G e M.Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities.Biochim Biophys Acta Rev Cancer.2023;1878:188928. – PubMed

Downloads

Published

2024-08-14

Issue

Vol. 2 No. 4 (2024): Volume 2, Issue 4

Section

Articles

License

Copyright (c) 2024 by the authors.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.